What is Clinuvel Pharmaceuticals 3-Year Dividend Growth Rate?
Clinuvel Pharmaceuticals's Dividends per Share for the
six
months ended in Dec. 2023 was €0.03.
The historical rank and industry rank for Clinuvel Pharmaceuticals's 3-Year Dividend Growth Rate or its related term are showing as below:
FRA:UR9'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 7.7 Med: 12.35 Max: 17
Current: 17
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Clinuvel Pharmaceuticals was 17.00% per year. The lowest was 7.70% per year. And the median was 12.35% per year.
FRA:UR9's 3-Year Dividend Growth Rate is ranked better than 53.03% of 66
companies
in the Biotechnology industry
Industry Median: 13
vs FRA:UR9: 17.00
During the past 12 months, Clinuvel Pharmaceuticals's average Dividends Per Share Growth Rate was 25.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 17.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Clinuvel Pharmaceuticals's Dividend Payout Ratio for the
six
months ended in Dec. 2023 was 0.24. As of today, Clinuvel Pharmaceuticals's Dividend Yield % is 0.34%.
Good Sign:
Clinuvel Pharmaceuticals Ltd stock dividend yield is close to 5-year high.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Clinuvel Pharmaceuticals's 3-Year Dividend Growth Rate
For the Biotechnology subindustry, Clinuvel Pharmaceuticals's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinuvel Pharmaceuticals's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Clinuvel Pharmaceuticals's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Clinuvel Pharmaceuticals's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Clinuvel Pharmaceuticals was 0.09. The lowest was 0.05. And the median was 0.06.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Clinuvel Pharmaceuticals Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
AUD 0.050
2023-09-05
2023-09-06
2023-09-20
Cash Dividend
annually
AUD:EUR 0.594682
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Clinuvel Pharmaceuticals's Dividend Yield (%) for Today is calculated as
Current Share Price is €8.935.
Clinuvel Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.0297341.
During the past 13 years, the highest Dividend Yield of Clinuvel Pharmaceuticals was 0.34%. The lowest was 0.05%. And the median was 0.11%.
Good Sign:
Clinuvel Pharmaceuticals Ltd stock dividend yield is close to 5-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinuvel Pharmaceuticals 3-Year Dividend Growth Rate Related Terms>
Clinuvel Pharmaceuticals (FRA:UR9) Business Description
Clinuvel distributes a single-product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:UR9 has been successfully added to your